BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33536988
Number of visits today
296
Number of downloads
16723508
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Menon I, Zaroudi M, Zhang Y, Aisenbrey E, Hui L. Fabrication of active targeting lipid nanoparticles: Challenges and perspectives. Materials Today Advances 2022;16:100299. [DOI: 10.1016/j.mtadv.2022.100299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Li M, Sun X, Yin M, Shen J, Yan S. Recent Advances in Nanoparticle-Mediated Co-Delivery System: A Promising Strategy in Medical and Agricultural Field. IJMS 2023;24:5121. [DOI: 10.3390/ijms24065121] [Reference Citation Analysis]
2 Marcello E, Chiono V. Biomaterials-Enhanced Intranasal Delivery of Drugs as a Direct Route for Brain Targeting. Int J Mol Sci 2023;24. [PMID: 36834804 DOI: 10.3390/ijms24043390] [Reference Citation Analysis]
3 Gonçalves A, Fernandes M, Lima M, Gomes JP, Silva F, Castro S, Sampaio F, Gomes AC. Nanotechnology to the Rescue: Therapeutic Strategies Based on Brown Algae for Neurodegenerative Diseases. Applied Sciences 2023;13:1883. [DOI: 10.3390/app13031883] [Reference Citation Analysis]
4 Xie Z, Wang J, Luo Y, Qiao B, Jiang W, Zhu L, Ran H, Wang Z, Zhu W, Ren J, Zhou Z. Tumor-penetrating nanoplatform with ultrasound "unlocking" for cascade synergistic therapy and visual feedback under hypoxia. J Nanobiotechnology 2023;21:30. [PMID: 36698190 DOI: 10.1186/s12951-023-01765-x] [Reference Citation Analysis]
5 Marques AC, Costa PC, Velho S, Amaral MH. Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy. Pharmaceutics 2023;15. [PMID: 36678845 DOI: 10.3390/pharmaceutics15010216] [Reference Citation Analysis]
6 Godbout K, Tremblay JP. Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy. Pharmaceutics 2022;14:2129. [PMID: 36297564 DOI: 10.3390/pharmaceutics14102129] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345